Bomedemstat
Imago BioSciences
[]
$imgo [15s. delayed]: issued press release on june 10, 03:00:00: imago biosciences presents positive data from ongoing phase 2 study of bomedemstat in advanced myelofibrosis at eha 2022 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time